• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文会议>International Forum on Management, Education and Information Technology Application >An Empirical Study on the Patent Quality of Vaccine Technology from China, the United States and Japan - Based on the Comparison of Legal Status, Maintenance Time and Citation Index of Vaccine Patents Granted in China
【24h】

An Empirical Study on the Patent Quality of Vaccine Technology from China, the United States and Japan - Based on the Comparison of Legal Status, Maintenance Time and Citation Index of Vaccine Patents Granted in China

机译：中国，美国和日本疫苗技术专利质量的实证研究 - 基于中国授予疫苗专利的法律地位，维护时间和引用指数的基于

获取原文
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Studying the patents granted in China in the field of vaccine technology, this paper conducts an empirical analysis on legal status, maintenance time and citation index of the vaccine patents from China, the United States and Japan. Based on a series of data, the paper draws the conclusion that: the vaccine patents from the United States are more stable and have higher technology maturity; the vaccine patents from Japan update with a quicker speed, and the patentees from Japan would like to take a short-duration patent strategy; as for vaccine patents from China, in general, the technology maturity, the update speed and the patent quality are inferior to those of the vaccine patents from the United States and Japan. Additionally, the Patent Citation Index of vaccine patents granted in China is quite low.
机译：本文研究了中国疫苗技术领域授予中国专利，对中国，美国和日本的疫苗专利的法律地位，维护时间和引文指数进行了实证分析。根据一系列数据，该论文得出了结论：美国的疫苗专利更稳定，具有更高的技术成熟;来自日本的疫苗专利以更快的速度更新，日本的专利人士希望采取短期持续的专利策略;对于来自中国的疫苗专利，一般来说，技术成熟，更新速度和专利质量不如来自美国和日本的疫苗专利。此外，中国授予的疫苗专利的专利引文指数相当低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号